EV-302: Impact of Enfortumab Vedotin + Pembrolizumab in Metastatic Bladder Cancer

News
Video

Shifting their focus to metastatic bladder cancer, the Oncology Brothers and Rana McKay, MD, reflect on data from EV-302 and consider how enfortumab vedotin + pembrolizumab has shifted the treatment landscape.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content